BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15046218)

  • 41. Stent-grafts for de novo TIPS: technique and early results.
    Andrews RT; Saxon RR; Bloch RD; Petersen BD; Uchida BT; Rabkin JM; Loriaux MM; Keller FS; Rösch J
    J Vasc Interv Radiol; 1999; 10(10):1371-8. PubMed ID: 10584654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J; Kroencke TJ; Schuetz T; Plauth M; Kasim E; Petersein J; Schmidt HH; Lochs H
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intractable hepatic encephalopathy after tips with polytetrafluoroethylene-covered stent-graft.
    Riggio O; Nicolao F; Angeloni S; Masini A; Salvatori F; Fanelli F; Efrati C; Merli M
    Scand J Gastroenterol; 2003 May; 38(5):570-2. PubMed ID: 12795474
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of covered stent length in portal and hepatic veins on long-term clinical efficacy of transjugular intrahepatic portosystemic shunt].
    Hu P; Chen SL; Lin ZP; Zhao JB; Chen Y; He XF; Zeng QL; Li YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1444-1448. PubMed ID: 27777214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.
    Stankovic G; Colombo A; Presbitero P; van den Branden F; Inglese L; Cernigliaro C; Niccoli L; Bartorelli AL; Rubartelli P; Reifart N; Heyndrickx GR; Saunamäki K; Morice MC; Sgura FA; Di Mario C;
    Circulation; 2003 Jul; 108(1):37-42. PubMed ID: 12821546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study.
    Maleux G; Perez-Gutierrez NA; Evrard S; Mroue A; Le Moine O; Laleman W; Nevens F
    Acta Gastroenterol Belg; 2010; 73(3):336-41. PubMed ID: 21086935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study.
    Vignali C; Bargellini I; Grosso M; Passalacqua G; Maglione F; Pedrazzini F; Filauri P; Niola R; Cioni R; Petruzzi P
    AJR Am J Roentgenol; 2005 Aug; 185(2):472-80. PubMed ID: 16037523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.
    Bureau C; Garcia-Pagan JC; Otal P; Pomier-Layrargues G; Chabbert V; Cortez C; Perreault P; Péron JM; Abraldes JG; Bouchard L; Bilbao JI; Bosch J; Rousseau H; Vinel JP
    Gastroenterology; 2004 Feb; 126(2):469-75. PubMed ID: 14762784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
    Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
    J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver infarction following TIPS with a PTFE-covered stent: is the covering the cause?
    LaBerge JM; Kerlan RK
    Hepatology; 2003 Sep; 38(3):778-9; author reply 779. PubMed ID: 12939608
    [No Abstract]   [Full Text] [Related]  

  • 52. Are TIPS stent-grafts a contraindication for future liver transplantation?
    Maleux G; Pirenne J; Vaninbroukx J; Aerts R; Nevens F
    Cardiovasc Intervent Radiol; 2004; 27(2):140-2. PubMed ID: 15259808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expanded PTFE-covered stent-grafts in the treatment of transjugular intrahepatic portosystemic shunt (TIPS) stenoses and occlusions.
    Echenagusia M; Rodriguez-Rosales G; Simo G; Camuñez F; Bañares R; Echenagusia A
    Abdom Imaging; 2005; 30(6):750-4. PubMed ID: 16245017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthesis: Prospective, Single-Center, Preliminary Experience.
    Miraglia R; Maruzzelli L; Di Piazza A; Mamone G; Caruso S; Gentile G; Tuzzolino F; Floridia G; Petridis I; Volpes R; Luca A
    Cardiovasc Intervent Radiol; 2019 Jan; 42(1):78-86. PubMed ID: 30073477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent TIPS failure associated with biliary fistulae: treatment with PTFE-covered stents.
    Sze DY; Vestring T; Liddell RP; Kato N; Semba CP; Razavi MK; Kee ST; Dake MD
    Cardiovasc Intervent Radiol; 1999; 22(4):298-304. PubMed ID: 10415219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Safety and clinical efficacy of TIPS with various stents for treatment of cirrhosis with esophageal gastric varices bleeding].
    Cai W; Zhuge Y; Zhang J; Li Z; He Q; Zhang M; Ni J; Li Y; Ma Q; Peng C
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):258-64. PubMed ID: 26133816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
    Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
    Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts.
    Weber CN; Nadolski GJ; White SB; Clark TW; Mondschein JI; Stavropoulos SW; Shlansky-Goldberg RD; Trerotola SO; Soulen MC
    J Vasc Interv Radiol; 2015 Sep; 26(9):1257-65; quiz 1265. PubMed ID: 25990133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-Transjugular Intrahepatic Portosystemic Shunt Follow-Up and Management in the VIATORR Era.
    Ferral H; Gomez-Reyes E; Fimmel CJ
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):82-8. PubMed ID: 26997092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.